Anti-atherogenic effect and cardiovascular benefit of GLP-1 receptor agonists

Overweight and obesity are currently among the most important risk factors: an increase in BMI of 5 kg/m2 leads to a 30% increase in overall mortality and a 40% increase in vascular mortality for coronary heart disease, cerebrovascular diseases, and other vascular diseases. PDF